<Suppliers Price>

Ex26

Names

[ CAS No. ]:
1233332-37-0

[ Name ]:
Ex26

[Synonym ]:
MFCD30537540
1-{[(5'-{[1-(4-Chloro-3-methylphenyl)ethyl]amino}-2'-fluoro-3,5-dimethyl-4-biphenylyl)carbonyl]amino}cyclopropanecarboxylic acid
Cyclopropanecarboxylic acid, 1-[[[5'-[[1-(4-chloro-3-methylphenyl)ethyl]amino]-2'-fluoro-3,5-dimethyl[1,1'-biphenyl]-4-yl]carbonyl]amino]-
Ex26
1-[[[5'-[[1-(4-Chloro-3-methylphenyl)ethyl]amino]-2'-fluoro-3,5-dimethyl[1,1'-biphenyl]-4-yl]carbonyl]amino]-cyclopropanecarboxylic acid
1-[[[5′-[[1-(4-Chloro-3-methylphenyl)ethyl]amino]-2′-fluoro-3,5-dimethyl[1,1′-biphenyl]-4-yl]carbonyl]amino]cyclopropanecarboxylic acid

Biological Activity

[Description]:

Ex26 (S1P1-IN-Ex26) is a potent and selective Sphingosine 1-phosphate receptor 1 (S1P1) antagonist (IC50=0.93 nM). Ex26 shows >3,000-fold selectivity for S1P1 over other Sphingosine 1-phosphate receptors. Ex26 can be used in experimental autoimmune encephalomyelitis reseach[1].

[Related Catalog]:

Signaling Pathways >> Others >> Others
Research Areas >> Inflammation/Immunology
Research Areas >> Metabolic Disease
Research Areas >> Neurological Disease

[Target]

IC50: 0.93 nM (S1P1)[1]


[In Vitro]

Ex26 (0-10 μM; 1 h) treatment shows excellent selectivity for S1P1 over other Sphingosine 1-phosphate receptors[1]. Cell Viability Assay[1] Cell Line: U2OS cells, and Chinese hamster ovary cells Concentration: 0-10 μM Incubation Time: 1 hour Result: Confirmed a potent and selective antagonist of S1P1 (IC50=0.93 nM).

[In Vivo]

Ex26 (i.p.; 3 mg/kg; once daily; 3 d) treatment disrupts S1P1 signaling inhibiting the lymphocyte and thymocyte egress[1]. Ex26 (i.p.; 30 mg/kg; once daily; 15 d) treatment alleviates experimental autoimmune encephalomyelitis by S1P1 antagonism[1]. Animal Model: Eight-week-old male C57Bl/6J mice[1] Dosage: 3 mg/kg Administration: Intraperitoneal injection; 3 mg/kg; once daily; 3 days Result: Induced lymphocyte sequestration at low doses, possessing an ED50 of 0.06 mg/kg after 2 hours treatment. Led to significant retention of T and B cells within the lymph nodes and significant decreases in T and B cells within the spleen. Animal Model: Eight-week-old male C57Bl/6J mice induced with experimental autoimmune encephalomyelitis[1] Dosage: 30 mg/kg Administration: Intraperitoneal injection; 30 mg/kg; once daily; 15 days Result: Inhibited both lymphocyte infiltration and destruction of the white matter in the spinal cord of mice euthanized at the end of the experiment.

[References]

[1]. Stuart M Cahalan, et al. Sphingosine 1-phosphate receptor 1 (S1P(1)) upregulation and amelioration of experimental autoimmune encephalomyelitis by an S1P(1) antagonist. Mol Pharmacol. 2013 Feb;83(2):316-21.

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
634.3±55.0 °C at 760 mmHg

[ Molecular Formula ]:
C28H28ClFN2O3

[ Molecular Weight ]:
494.98

[ Flash Point ]:
337.4±31.5 °C

[ Exact Mass ]:
494.177246

[ LogP ]:
6.12

[ Vapour Pressure ]:
0.0±2.0 mmHg at 25°C

[ Index of Refraction ]:
1.639

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.